Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae.

Détails

Ressource 1Télécharger: BIB_AEC3046A1432.P001.pdf (207.34 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_AEC3046A1432
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae.
Périodique
BMC Microbiology
Auteur(s)
Cottagnoud P., Entenza J.M., Cottagnoud M., Que Y.A., Moreillon P., Taüber M.G.
ISSN
1471-2180 (Electronic)
ISSN-L
1471-2180
Statut éditorial
Publié
Date de publication
2001
Volume
1
Pages
9
Langue
anglais
Résumé
BACKGROUND: The continuous spread of penicillin-resistant pneumococci represents a permanent threat in the treatment of pneumococcal infections, especially when strains show additional resistance to quinolones. The main objective of this study was to determine a treatment modality impeding the emergence of quinolone resistance. RESULTS: Exposure of a penicillin-resistant pneumococcus to increasing concentrations of trovafloxacin or ciprofloxacin selected for mutants resistant to these drugs. In the presence of sub-inhibitory concentrations of vancomycin, development of trovafloxacin-resistance and high-level ciprofloxacin-resistance were prevented. CONCLUSIONS: Considering the risk of quinolone-resistance in pneumococci, the observation might be of clinical importance.
Mots-clé
4-Quinolones, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Drug Interactions, Drug Resistance, Bacterial/physiology, Microbial Sensitivity Tests, Penicillin Resistance/physiology, Streptococcus pneumoniae/drug effects, Vancomycin/pharmacology
Pubmed
Création de la notice
24/01/2008 13:45
Dernière modification de la notice
20/08/2019 15:18
Données d'usage